Stanford Med Students Offered Option to Study Their Own Genotype Data
By GenomeWeb,
GenomeWeb Daily News
| 06. 07. 2010
Stanford University School of Medicine today said that it will offer a new course that gives medical and graduate students an option to study their personal genotype data.
The university said that it believes it is the first medical school to offer students such a course. However, the University of Pennsylvania School of Medicine offered its fourth-year medical students a similar course in personalized medicine this past year.
In the Stanford course, students will learn how to analyze, evaluate, and interpret the genetic data, the limitations of existing technologies, and the legal and ethical issues surrounding personal genotyping.
The course will be an elective and will be offered during the school's summer quarter, which begins June 21.
The UPenn course also included a discussion of the ethical, legal, and social implications of personalized medicine, according to Professor Reed Pyeritz, who offered the course and is director of the school's Center for the Integration of Genetic Healthcare Technologies. Students in the UPenn course were offered an option to have their genome scanned by the Coriell Personalized Medicine Collaborative.
Recently, the University...
Related Articles
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
